Clinical Trial Update: Efficacy and Safety of HRS9531 Tablet in Obese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating HRS9531 Tablet for obesity in adults has completed, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HRS9531 Tablet

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Chronic Management of Body Weight | Phase 2 | Status: COMPLETED